PYC Therapeutics (ASX:PYC) Gross Property, Plant and Equipment: A$1.64 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:PYC PYC Therapeutics Ltd ASX:PYC
33 GF Score
Price A$1.62
! 2 Warning Signs
View Full Analysis

What is PYC Therapeutics Gross Property, Plant and Equipment?

PYC Therapeutics ASX:PYC +6.60% 33 Gross Property, Plant and Equipment is A$1.64 Mil as of Dec. 2025. GuruFocus rates ASX:PYC with a GF Score™ of 33/100. The stock has 2 warning signs investors should review.

PYC Therapeutics's quarterly gross PPE increased from Dec. 2024 (A$2.15 Mil) to Jun. 2025 (A$6.83 Mil) but then declined from Jun. 2025 (A$6.83 Mil) to Dec. 2025 (A$1.64 Mil).

PYC Therapeutics's annual gross PPE increased from Jun. 2023 (A$4.19 Mil) to Jun. 2024 (A$5.59 Mil) and increased from Jun. 2024 (A$5.59 Mil) to Jun. 2025 (A$6.83 Mil).


PYC Therapeutics  (ASX:PYC) Gross Property, Plant and Equipment Explanation

A company with durable competitive advantage doesn't need to constantly upgrade its equipment to stay competitive. The company replaces when it wears out. On the other hand, a company without any advantages must replace to keep pace.

Difference between a company with a moat and one without is that the company with the competitive advantage finances new equipment through internal cash flows, whereas the no advantage company requires debt to finance.

Producing a consistent product that doesn't change equates to consistent profits. There is no need to upgrade plants which frees up cash for other ventures. Think Coca Cola, Johnson & Johnson etc.


PYC Therapeutics Gross Property, Plant and Equipment Related Terms


PYC Therapeutics Gross Property, Plant and Equipment Historical Data

* Premium members only.

The historical data trend for PYC Therapeutics's Gross Property, Plant and Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PYC Therapeutics Gross Property, Plant and Equipment Chart

PYC Therapeutics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Gross Property, Plant and Equipment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.53 4.31 4.19 5.59 6.83

PYC Therapeutics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Gross Property, Plant and Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.21 5.59 2.15 6.83 1.64
ASX:PYC
33GF Score
PYC Therapeutics Ltd ASX:PYC
Gross Property, Plant and Equipment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PYC Therapeutics Gross Property, Plant and Equipment Calculation

Property, Plant and Equipment (PPE) are the fixed assets of the company. Fixed assets are also known as non-current assets.

Property, plant, and equipment includes assets that will - in the normal course of business - neither be used up in the next year nor will become a part of any product sold to customers.

Some of the most common parts of property, plant, and equipment are:


Land
Buildings (and leasehold improvements)
Transportation equipment
Manufacturing equipment
Office equipment
Office furniture

Companies with lots of property, plant, and equipment often have special categories. For example, railroad property includes:


Track
Ties
Ballast
Bridges
Tunnels
Signals
Locomotives
Freight Cars

There is often a note in the financial statements - found in a company's 10-K - that will explain the different categories of property a company owns.

The market value of property, plant, and equipment can differ tremendously from the book value of property, plant, and equipment.

For example, when Berkshire Hathaway liquidated its textile mills, it had to pay the buyers of the company's manufacturing equipment to haul the equipment away. That property, plant, and equipment was literally worth less than zero. On the other hand, some companies own thousands of acres of land.

All property, plant, and equipment other than land is depreciated. Land is never depreciated. However, land is not marked up to market value either. Under Generally Accepted Accounting Principles (GAAP), land is shown on the balance sheet at cost.

The property, plant, and equipment line shown on the balance sheet is usually net property, plant, and equipment. This means it is the cost of the property, plant, and equipment less accumulated depreciation.

What does a Gross Property, Plant and Equipment of A$1.64 Mil mean?
PYC Therapeutics (ASX:PYC) has a Gross Property, Plant and Equipment of A$1.64 Mil as of Dec. 2025. The total gross property, plant and equipment assets recorded on a company's balance sheet. View historical data on PYC Therapeutics and its competitors.
Is PYC Therapeutics' Gross Property, Plant and Equipment too high?
PYC Therapeutics' current Gross Property, Plant and Equipment is A$1.64 Mil. Overall, PYC Therapeutics has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does PYC Therapeutics' Gross Property, Plant and Equipment compare to VRTX and REGN?
PYC Therapeutics' Gross Property, Plant and Equipment of A$1.64 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Property, Plant and Equipment for a Biotechnology company?
A good Gross Property, Plant and Equipment depends on the Biotechnology industry context. However, Gross Property, Plant and Equipment should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Property, Plant and Equipment mean?
A high Gross Property, Plant and Equipment can signal that a stock is expensive relative to its fundamentals. The total gross property, plant and equipment assets recorded on a company's balance sheet. View historical data on PYC Therapeutics and its competitors. PYC Therapeutics's current Gross Property, Plant and Equipment is A$1.64 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PYC Therapeutics stock overvalued right now?
PYC Therapeutics (ASX:PYC) has a current Gross Property, Plant and Equipment of A$1.64 Mil. The current Gross Property, Plant and Equipment is A$1.64 Mil. PYC Therapeutics' overall GF Score™ is 33/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Property, Plant and Equipment calculated?
Gross Property, Plant and Equipment is calculated from a company's financial statements. For PYC Therapeutics (ASX:PYC), the current Gross Property, Plant and Equipment is A$1.64 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PYC Therapeutics Business Description

Other Exchanges PYCXF:USA
Address 6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.
33GF Score

Get the complete analysis for ASX:PYC

Gross Property, Plant and Equipment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$1.62
Price